Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Altice Terug naar discussie overzicht

Altice Europe Februari 2019

424 Posts
Pagina: «« 1 ... 17 18 19 20 21 22 | Laatste | Omlaag ↓
  1. forum rang 4 UpandDown 1 maart 2019 10:09
    Ik heb liever dat het rustig aan stijgt en dan eind van de dag een eindsprint maakt. In plaats van een grote stijging in de ochtend en dan alles weer zien verdampen in de loop van de dag. Zo vaak is dat het geval geweest de afgelopen weken
  2. [verwijderd] 1 maart 2019 10:15
    quote:

    UpandDown schreef op 1 maart 2019 10:09:

    Ik heb liever dat het rustig aan stijgt en dan eind van de dag een eindsprint maakt. In plaats van een grote stijging in de ochtend en dan alles weer zien verdampen in de loop van de dag. Zo vaak is dat het geval geweest de afgelopen weken
    Dat klopt. Als het maar stijgt :)
  3. forum rang 4 UpandDown 5 maart 2019 17:13
    Omwisselen naar het FransAOF) - Although the competitive environment has improved since the third quarter of 2018 in the telecoms sector in France, a sustainable operator discipline remains uncertain. This is what Barclays observes, which paints a gloomy picture of the sector. Thus, Iliad (-2.89% to 90.60 euros), Altice (-8.97% to 1.88 euros) and Bouygues (-1.10% to 32.48 euros) are penalized on the place of Paris . For its part, Orange (+ 0.11% to 13.33 euros) resists this pessimistic view.
    Describing "irrational" promotions during the fiscal year, Barclays believes that "prolonged healing of the market is necessary" to protect the profitability of the sector.
    But the durability of this healing is uncertain with four players, who have contradictory objectives according to the broker: gain market share for Iliad and Bouygues, protection of market share for Orange, and finally return to the stabilization of revenues for Altice.
    In this context, Barclays expects the turnover of the French market in 2019 to deteriorate compared to 2018 and is at the lower end of the spectrum compared to its European peers.
    With this in mind, the analysis office posts its caution for 2019, and downgraded certain recommendations.
    Thus, Orange and Iliad switch from Overweight to Neutral, with respective price targets adjusted from 18.50 to 16.50 euros, and from 145 to 105 euros.
    Orange withstood competitive pressure in 2018 thanks to its difference based on quality, but the year 2019 should prove more difficult underlines Barclays.
    As for Iliad, the group has launched new initiatives to better segment its market and is investing heavily in 4G coverage and FTTH. "However, catching the 4G bandwidth, and therefore the perception of quality, will take time," said the British bank.
    For its part, Altice goes from Neutral to Underweight, and sees its price target passed from 2.80 to 1.5 euro, after a difficult year operationally.
    Only Bouygues keeps his advice Neutral, and sees his price target adjusted from 39 to 37 euros.
    Faced with this dark vision of the future of French telecoms, Barclays believes that the consolidation of the market would be the best option, even if it seems unlikely in the short term.
424 Posts
Pagina: «« 1 ... 17 18 19 20 21 22 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.842
AB InBev 2 5.291
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.539
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.969
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.545
Aedifica 2 832
Aegon 3.257 320.149
AFC Ajax 537 7.018
Affimed NV 2 5.763
ageas 5.843 109.779
Agfa-Gevaert 13 1.864
Ahold 3.536 74.001
Air France - KLM 1.024 34.365
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.774
Alfen 12 16.616
Allfunds Group 3 1.223
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 339
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.767
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.405
AMG 965 126.191
AMS 3 73
Amsterdam Commodities 303 6.524
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.173
Apollo Alternative Assets 1 17
Apple 5 321
Arcadis 251 8.626
Arcelor Mittal 2.024 318.707
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.148
Aroundtown SA 1 179
Arrowhead Research 5 9.284
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.729
ASML 1.762 77.195
ASR Nederland 18 4.129
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.694
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 09 mei

    1. China handelsbalans april
    2. Argenx Q1-cijfers
    3. Hemelvaartsdag, Euronext Amsterdam regulier open
    4. Philips €0,85 ex-dividend
    5. DSM-Firmenich €2,50 ex-dividend
    6. Allfunds €0,0935 ex-dividend
    7. Coca-Cola EP €0,74 ex-dividend
    8. TKH €1,70 ex-dividend
    9. Bank of England - rentebesluit Onveranderd (5,25%)
    10. VS steunaanvragen - wekelijks
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht